Search

Napoleone M Ferrara

from San Diego, CA
Age ~68
Get Report
Also known as:
Napoleone H Ferrara, Napoleon Ferrara, Napoleo H Ferrara, Napoleone Ferrera, Ferrara Napoleone, Ferrera Napoleone
Related to:
Natalie Wildenradt, 32Jennifer F Wildenradt, 68Theodore H WildenradtVernelle G WildenradtDuane C Wildenradt, 71Eric T Wildenradt, 74Saito Saito Chica, 62Ara Chica R
Connected to:
Al Ferrara, 85Alan J Ferrara, 73Albert M Ferrara, 59Alexa M Ferrara, 37Andre D Ferrara, 63Angie Ferrara, 37Attilio Ferrara, 43Benny Ferrara, 64Brianna J Ferrara, 33Bryce Ferrara, 35

Napoleone Ferrara Phones & Addresses

  • San Diego, CA
  • 2090 Pacific Ave, San Francisco, CA 94109 (415) 885-4021
  • Redding, CA
  • Belvedere Tiburon, CA

Work

Company: Genentech Position: Genentech fellow at genentech

Industries

Biotechnology

Resumes

Resumes

Napoleone Ferrara Photo 1

Genentech Fellow At Genentech

View page
Location:
San Francisco, CA
Industry:
Biotechnology
Work:
Genentech
Genentech Fellow at Genentech

Publications

Wikipedia References

Napoleone Ferrara Photo 2

Napoleone Ferrara

Work:

He is credited with identifying the human Vascular endothelial growth factor gene and describing its angiogenesis properties,.

Education:
Specialty:

Molecular biologist

Skills & Activities:

" Napoleone Ferrara ", M. D., Ph. D. is an Italian-American molecular biologist and is a Genentech Fellow in tumor biology and angiogenesis.

Napoleone Ferrara Photo 3

Napoleone Ferrara

Isbn (Books And Publications)

Tumour Angiogenesis

View page
Author

Napoleone Ferrara

ISBN #

0198549377

Us Patents

Tie Receptor Tyrosine Kinase Ligand Homologues

View page
US Patent:
6348351, Feb 19, 2002
Filed:
Dec 8, 1998
Appl. No.:
09/202089
Inventors:
Sherman Fong - Alameda CA
Napoleone Ferrara - San Francisco CA
Audrey Goddard - San Francisco CA
Paul J. Godowski - Burlingame CA
Austin L. Gurney - Belmont CA
Kenneth Hillan - San Francisco CA
P. Mickey Williams - Half Moon Bay CA
Assignee:
Genentech, Inc. - South SanFrancisco CA
International Classification:
C07K 14475
US Classification:
435325, 536 231, 536 235, 530350, 435 691, 4353201, 4352523, 43525411
Abstract:
The present invention concerns isolated nucleic acid molecules encoding the novel TIE ligand homologues NL2, NL3 and NL6 (FLS139), the proteins encoded by such nucleic acid molecules, as well as methods and means for making and using such nucleic acid and protein molecules.

Inhibitors Of Vascular Endothelial Growth Factor Activity, Their Uses And Processes For Their Production

View page
US Patent:
6383486, May 7, 2002
Filed:
Jul 1, 1999
Appl. No.:
09/348886
Inventors:
Terri Lynn Davis-Smyth - Foster City CA
Helen Hsifei Chen - Daly City CA
Leonard Presta - San Francisco CA
Napoleone Ferrara - San Francisco CA
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
A61K 39395
US Classification:
4241581, 514 2, 530350, 530324
Abstract:
The present invention is directed to novel chimeric VEGF receptor proteins comprising amino acid sequences derived from the vascular endothelial growth factor (VEGF) receptors flt-1 and KDR, including the murine homologue to the human KDR receptor FLK-1, wherein said chimeric VEGF receptor proteins bind to VEGF and antagonize the endothelial cell proliferative and angiogenic activity thereof. The present invention is also directed to nucleic acids and expression vectors encoding these chimeric VEGF receptor proteins, host cells harboring such expression vectors, pharmaceutically acceptable compositions comprising such proteins, methods of preparing such proteins and to methods utilizing such proteins for the treatment of conditions associated with undesired vascularization.

Polypeptides Having Homology To Vascular Endothelial Cell Growth Factor And Bone Morphogenetic Protein 1

View page
US Patent:
6391311, May 21, 2002
Filed:
Mar 17, 1998
Appl. No.:
09/040220
Inventors:
Napoleone Ferrara - San Francisco CA
Sophia S. Kuo - San Francisco CA
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
A61K 3818
US Classification:
4241981, 4241921, 530399, 435 697, 435 691
Abstract:
The present invention involves the identification and preparation of vascular endothelial growth factor-E (VEGF-E). VEGF-E is a novel polypeptide related to vascular endothelial growth factor (VEGF) and bone morphogenetic protein 1. VEGF-E has homology to VEGF including conservation of the amino acids required for activity of VEGF. VEGF-E is shown herein to induce enhanced survival of cells, proliferation of cells and hypertrophy of cells. Thus, VEGF-E can be useful in wound repair, as well as the generation and regeneration of tissue.

Nl4 Tie Ligand Homologue Nucleic Acid

View page
US Patent:
6413770, Jul 2, 2002
Filed:
Aug 19, 1998
Appl. No.:
09/136801
Inventors:
Paul Godowski - Burlingame CA
Austin Gurney - Belmont CA
Kenneth J. Hillan - San Francisco CA
David Botstein - Belmont CA
Audrey Goddard - San Francisco CA
Margaret Roy - San Francisco CA
Napoleone Ferrara - San Francisco CA
Daniel Tumas - Orinda CA
Ralph Schwall - Pacifica CA
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
C07K 14475
US Classification:
435325, 536 231, 536 235, 435 691, 4353201, 4352523, 43525411, 530350
Abstract:
The present invention concerns isolated nucleic acid molecules encoding the novel TIE ligands NL1, NL5, NL8, and NL4, the proteins encoded by such nucleic acid molecules, as well as methods and means for making and using such nucleic acid and protein molecules.

Nucleic Acids Encoding Vascular Endothelial Cell Growth Factor-E (Vegf-E)

View page
US Patent:
6455283, Sep 24, 2002
Filed:
Mar 10, 1999
Appl. No.:
09/265686
Inventors:
Napoleone Ferrara - San Francisco CA
Sophia S. Kuo - San Francisco CA
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
C12N 1518
US Classification:
435 694, 435 691, 43525233, 435360, 4352542, 435348, 4353201, 536 2351, 530399
Abstract:
The present invention involves the identification and preparation of vascular endothelial growth factor-E (VEGF-E). VEGF-E is a novel polypeptide related to vascular endothelial growth factor (VEGF) and bone morphogenetic protein 1. VEGF-E has homology to VEGF including conservation of the amino acids required for activity of VEGF. VEGF-E can be useful in wound repair, as well as in the generation and regeneration of tissue.

Nl4 Tie Ligand Homologue

View page
US Patent:
6551822, Apr 22, 2003
Filed:
Dec 8, 1998
Appl. No.:
09/202088
Inventors:
Paul J. Godowski - Burlingame CA
Austin L. Gurney - Belmont CA
Kenneth Hillan - San Francisco CA
David Botstein - Belmont CA
Audrey Goddard - San Francisco CA
Margaret Roy - San Francisco CA
Napoleone Ferrara - San Francisco CA
Daniel Tumas - Orinda CA
Ralph Schwall - Pacifica CA
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
C07K 14475
US Classification:
435325, 530300, 530350, 530402, 4241921, 536 231, 536 235, 435 691, 435 697, 4353201, 4352523, 43525411, 514 2
Abstract:
The present invention concerns isolated nucleic acid molecules encoding the novel TIE ligands NL1, NL5, NL8, and NL4, the proteins encoded by such nucleic acid molecules, as well as methods and means for making and using such nucleic acid and protein molecules.

Uses Of Vegf-E

View page
US Patent:
6620784, Sep 16, 2003
Filed:
Nov 27, 2000
Appl. No.:
09/723749
Inventors:
Napoleone Ferrara - San Francisco CA
Sophia S. Kuo - San Francisco CA
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
A61K 3818
US Classification:
514 12, 514 2, 530399
Abstract:
The present invention involves the identification and preparation of vascular endothelial growth factor-E (VEGF-E). VEGF-E is a novel polypeptide related to vascular endothelial growth factor (VEGF) and bone morphogenetic protein 1. VEGF-E has homology to VEGF including conservation of the amino acids required for activity of VEGF. VEGF-E can be useful in wound repair, as well as in the generation and regeneration of tissue.

Secreted And Transmembrane Polypeptides And Nucleic Acids Encoding The Same

View page
US Patent:
6635468, Oct 21, 2003
Filed:
Jul 17, 2001
Appl. No.:
09/907794
Inventors:
Avi Ashkenazi - San Mateo CA
David Botstein - Belmont CA
Luc Desnoyers - San Francisco CA
Dan L. Eaton - San Rafael CA
Napoleone Ferrara - San Francisco CA
Ellen Filvaroff - San Francisco CA
Sherman Fong - Alameda CA
Wei-Qiang Gao - Palo Alto CA
Hanspeter Gerber - San Francisco CA
Mary E. Gerritsen - San Mateo CA
Audrey Goddard - San Francisco CA
Paul J. Godowski - Hillsborough CA
J. Christopher Grimaldi - San Francisco CA
Austin L. Gurney - Belmont CA
Kenneth J. Hillan - San Francisco CA
Ivar J. Kljavin - Pacifica CA
Jennie P. Mather - Millbrae CA
James Pan - Zitobicoke, CA
Nicholas F. Paoni - Granger IN
Margaret Ann Roy - San Francisco CA
Timothy A. Stewart - San Francisco CA
Daniel Tumas - Orinda CA
P. Mickey Williams - Half Moon Bay CA
William I. Wood - Hillsborough CA
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
C12N 121
US Classification:
4352523, 435 691, 43525411, 435325, 4353201, 536 231, 536 235, 536 241
Abstract:
The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

Wikipedia

Napolee Ferrara

View page

Napoleone Ferrara, M.D., Ph.D. is an Italian-American molecular biologist and is currently a Genentech Fellow in tumor biology and angiogenesis. ...
Control profile
Napoleone M Ferrara from San Diego, CA, age ~68 Get Report